Results 121 to 130 of about 1,124,617 (208)

NOVO RJEŠENJE ZAGONETKE DIJELJENJA POLA-POLA U NAPOLIČARENJU

Economic research - Ekonomska istraživanja, 2013
This paper mainly discusses the puzzle of fifty-fifty split in sharecropping through an improved principal-agent moral hazard framework. Greatly different from the existing literature, this paper finds a new solution to the puzzle of fifty-fifty split in sharecropping.
openaire   +1 more source

POLA-POLA PENGGUNAAN KECERDASAN ARTIFISIAL DALAM PENELITIAN KEAMANAN PANGAN

Djtechno: Jurnal Teknologi Informasi
Penelitian ini mengkaji penggunaan kecerdasan buatan (AI) dalam meningkatkan ketahanan pangan melalui tinjauan sistematis dan analisis bibliometrik. Dengan meningkatnya tantangan global seperti perubahan iklim dan pertumbuhan populasi, AI menawarkan solusi inovatif dalam sektor pangan.
openaire   +1 more source

Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER). [PDF]

Jpn J Clin Oncol
Sano Y, Miyazaki K, Yamaguchi M, Taguchi S, Machida R, Kawabata K, Fukuda H, Shimada K, Nagai H, Munakata W, Maruyama D, Japan Clinical Oncology Group Lymphoma Study Group.   +11 more
europepmc   +1 more source

[Indications for lumbar spine radiography in Primary Care: interpretation beyond the image]. [PDF]

Aten Primaria
Toranzo-Benítez J, Aispuru-Lanche R.
europepmc   +1 more source

External quality assessment for yaws elimination in low- and middle-income countries using plasmid-based proficiency test items. [PDF]

PLoS Negl Trop Dis
Mueller C, Tchatchouang S, Basing LA, Ngazoa-Kakou S, Hugues KA, Handley BL, Beiras CG, Amanor IB, Ndzomo P, Bakheit MA, Becherer L, Tabah EN, Crucitti T, Borst N, Ries C, Lueert S, Frischmann S, Gmoser H, Landmann E, Sylla A, Kouamé-Sina SM, Arhinful D, Awondo P, Burl S, Harding-Esch EM, Tano A, Mitjà O, Eyangoh S, Addo KK, Marks M, Knauf S.   +30 more
europepmc   +1 more source

Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration. [PDF]

Blood Adv
Gao L, Kallam A, Shouse G, Baird JH, Pak S, Qin Y, Song JY, Marcucci G, Ghoda LY, Guillen C, Hyung SJ, Saad OM, Davis H, Dere R, Batlevi CL, Meinert J, Budde LE, Danilov AV, Herrera AF, Kwak LW, Forman SJ, Godfrey JK.   +21 more
europepmc   +1 more source

Neuropeptide Y regulation of dental pulp neurogenic inflammation provoked by tooth bleaching agents: a descriptive comparative clinical study. [PDF]

Restor Dent Endod
Caviedes-Bucheli J, Ríos-Osorio N, Pérez-Villota M, Aucú-Miño K, Escobar-Mafla D, Muñoz-Alvear HD, Gomez-Sosa JF, Diaz-Barrera L, Güiza-Cristancho E, Munoz HR.   +9 more
europepmc   +1 more source

Polatuzumab vedotin-R-CHP used for high-risk EBV-negative DLBCL-type post-transplant lymphoproliferative disorder in a long-term kidney transplant recipient: a case report. [PDF]

Front Oncol
Jiang X, Wu C, Zhang YO, Luo M, Qiu Y, Li M, Zhan L, Zhong D.   +7 more
europepmc   +1 more source

2026 Update on the Management of Diffuse Large B-Cell Lymphoma. [PDF]

Am J Hematol
Chong EA, Tomasulo EB, Barta SK.
europepmc   +1 more source

Current evidence and strategies for bridging therapy in CD19-directed chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphomas. [PDF]

Ann Hematol
Lv J, Xie Y, Zhang C, Deng J, Song Y, Zhu J.   +5 more
europepmc   +1 more source